5-nitro-2-(3-phenylpropylamino)benzoic acid has been researched along with Cardiovascular Stroke in 1 studies
5-nitro-2-(3-phenylpropylamino)benzoic acid: structure given in first source; chloride channel antagonist
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Souktani, R | 1 |
| Ghaleh, B | 1 |
| Tissier, R | 1 |
| d'Anglemont de Tassigny, A | 1 |
| Aouam, K | 1 |
| Bedossa, P | 1 |
| Charlemagne, D | 1 |
| Samuel, J | 1 |
| Henry, P | 1 |
| Berdeaux, A | 1 |
1 other study available for 5-nitro-2-(3-phenylpropylamino)benzoic acid and Cardiovascular Stroke
| Article | Year |
|---|---|
Inhibitors of swelling-activated chloride channels increase infarct size and apoptosis in rabbit myocardium.
Topics: Animals; Apoptosis; Chloride Channels; Glycolates; Male; Myocardial Infarction; Myocardium; Nitroben | 2003 |